SEC 13D/G

GRCE - Grace Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks Simplified

$GRCE$2.17▼ -40.55% YTDHealthcareAug 7, 2026 · ThinkSabio Blog

Keywords

GRCEGRCE SEC filingGRCE institutional investorGrace TherapeuticsInc.Grace TherapeuticsInc. SEC filingGrace TherapeuticsInc. stockSEC 13DSEC 13GThinkSabiostocks simplifiedHealthcareSEC 13D/Gstock market 2026institutional holdings

SEC Filing Update: #GRCE Grace Therapeutics, Inc. : $2.17

Sector: Healthcare | YTD: 🔽 -40.55% The SEC disclosed Today (07-AUG-2026) that OPALEYE MANAGEMENT INC has Newly bought 2,748,392 #GRCE shares Ownership: 13.07% * Estimated Investment Value: $5.91M https://www.thinksabio.com/reports/isr/GRCE

Share this post

💬 Comments

Loading comments…